Professor Nicola Dalbeth
MBChB MD FRACP
Nicola Dalbeth is an academic rheumatologist who leads a clinical and laboratory programme of research in gout, an inflammatory arthritis of major significance to Aotearoa New Zealand. Her work focuses on understanding the impact and mechanisms of disease in gout.
She has been lead investigator in both commercial and investigator-initiated clinical trials in gout. She is a founding member of the Counties Manukau District Health Board Māori Gout Action Group. She chairs the Atlas of Healthcare Variation Gout Expert Advisory Group, and Australia and New Zealand Gout Special Interest Forum. She was the Lead Clinical Advisor for the Gout Clinical Pathways (Greater Auckland Integrated Healthcare Network) and the national bpac Gout Treatment Guidelines. She has served as an Expert Panel member on the American College of Rheumatology Gout Management Guidelines, and is a steering committee member for the OMERACT gout working group and the ACR/EULAR gout classification project.
Research | Current
Clinical research includes clinical trials, imaging studies (using plain radiographs, MRI and three-dimensional CT modeling) to analyze joint damage, studies to investigate the functional impact of gout, and validation of outcome measures in gout. The laboratory work in the Auckland Bone and Joint Research Laboratory involves investigating the cellular and molecular mechanisms of inflammation and joint damage in gout.
Selected publications and creative works (Research Outputs)
- Bursill, D., Taylor, W. J., Terkeltaub, R., Abhishek, A., So, A. K., Vargas-Santos, A. B., ... Reginato, A. (2019). Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Annals of the rheumatic diseases10.1136/annrheumdis-2019-215933
- Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Merriman, T. R., ... Dalbeth, N. (2019). Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration. Clinical and translational science10.1111/cts.12686
Other University of Auckland co-authors: Anne Horne
- Serlachius, A., Schache, K., Kieser, A., Arroll, B., Petrie, K., & Dalbeth, N. (2019). Association Between User Engagement of a Mobile Health App for Gout and Improvements in Self-Care Behaviors: Randomized Controlled Trial. JMIR mHealth and uHealth, 7 (8)10.2196/15021
Other University of Auckland co-authors: Anna Serlachius, Bruce Arroll, Keith Petrie
- Stewart, S., Maxwell, H., & Dalbeth, N. (2019). Prevalence and discrimination of OMERACT-defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricaemia: A systematic review and meta-analysis. SEMINARS IN ARTHRITIS AND RHEUMATISM, 49 (1), 62-73. 10.1016/j.semarthrit.2019.01.004
- Fogarty, F. A., Booth, R. J., Lee, A. C., Dalbeth, N., & Consedine, N. S. (2019). Mindfulness-Based Stress Reduction with Individuals Who Have Rheumatoid Arthritis: Evaluating Depression and Anxiety as Mediators of Change in Disease Activity. MINDFULNESS, 10 (7), 1328-1338. 10.1007/s12671-018-1090-1
Other University of Auckland co-authors: Arier Lee, Roger Booth, Nathan Consedine
- Lu, J., Dalbeth, N., Yin, H., Li, C., Merriman, T. R., & Wei, W.-H. (2019). Mouse models for human hyperuricaemia: a critical review. Nature reviews. Rheumatology, 15 (7), 413-426. 10.1038/s41584-019-0222-x
- Dalbeth, N., Frampton, C., Fung, M., Baumgartner, S., Nicolaou, S., & Choi, H. K. (2019). Concurrent validity of provisional remission criteria for gout: a dual-energy CT study. Arthritis research & therapy, 21 (1)10.1186/s13075-019-1941-8
- Krasnoryadtseva, A., Dalbeth, N., & Petrie, K. (2019). Does seeing personal medical images change beliefs about illness and treatment in people with gout? A randomised controlled trial. PSYCHOLOGY & HEALTH10.1080/08870446.2019.1626396
Other University of Auckland co-authors: Keith Petrie